Tom Birger Granström
Kagawa University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tom Birger Granström.
Journal of Bioscience and Bioengineering | 2004
Tom Birger Granström; Goro Takata; Masaaki Tokuda; Ken Izumori
Starch, whey or hemicellulosic waste can be used as a raw material for the industrial production of rare sugars. D-glucose from starch, whey and hemicellulose, D-galactose from whey, and D-xylose from hemicellulose are the main starting monosaccharides for production of rare sugars. We can produce all monosaccharides; tetroses, pentoses and hexoses, from these raw materials. This is achieved by using D-tagatose 3-epimerase, aldose isomerase, aldose reductase, and oxidoreductase enzymes or whole cells as biocatalysts. Bioproduction strategies for all rare sugars are illustrated using ring form structures given the name Izumoring.
Applied Microbiology and Biotechnology | 2007
Tom Birger Granström; Ken Izumori; Matti Leisola
Xylitol is the first rare sugar that has global markets. It has beneficial health properties and represents an alternative to current conventional sweeteners. Industrially, xylitol is produced by chemical hydrogenation of d-xylose into xylitol. The biotechnological method of producing xylitol by metabolically engineered yeasts, Saccharomyces cerevisiae or Candida, has been studied as an alternative to the chemical method. Due to the industrial scale of production, xylitol serves as an inexpensive starting material for the production of other rare sugars. The second part of this mini-review on xylitol will look more closely at the biotechnological production and future applications of the rare sugar, xylitol.
Applied Microbiology and Biotechnology | 2007
Tom Birger Granström; Ken Izumori; Matti Leisola
The rare sugar xylitol is a five-carbon polyol (pentitol) that has beneficial health effects. Xylitol has global markets and, therefore, it represents an alternative to current dominant sweeteners. The research on microbial reduction of d-xylose to xylitol has been focused on metabolically engineered Saccharomycess cerevisiae and Candida strains. The Candida strains have an advantage over the metabolically engineered S. cerevisiae in terms of d-xylose uptake and maintenance of the intracellular redox balance. Due to the current industrial scale production of xylitol, it has become an inexpensive starting material for the production of other rare sugar. The first part of this mini-review concentrates on the biochemistry of xylitol biosynthesis and the problems related to intracellular redox balance.
Biochimica et Biophysica Acta | 2004
Khim Leang; Goro Takada; Yoshinori Fukai; Kenji Morimoto; Tom Birger Granström; Ken Izumori
Journal of Bioscience and Bioengineering | 2006
Buetusiwa Thomas Menavuvu; Wayoon Poonperm; Khim Leang; Naoki Noguchi; Hiromi Okada; Kenji Morimoto; Tom Birger Granström; Goro Takada; Ken Izumori
Enzyme and Microbial Technology | 2006
Kenji Morimoto; Chang-su Park; Motofumi Ozaki; Kei Takeshita; Tsuyoshi Shimonishi; Tom Birger Granström; Goro Takata; Masaaki Tokuda; Ken Izumori
Applied Microbiology and Biotechnology | 2007
Wayoon Poonperm; Goro Takata; Hiromi Okada; Kenji Morimoto; Tom Birger Granström; Ken Izumori
Journal of Bioscience and Bioengineering | 2006
Buetusiwa Thomas Menavuvu; Wayoon Poonperm; Kosei Takeda; Kenji Morimoto; Tom Birger Granström; Goro Takada; Ken Izumori
Enzyme and Microbial Technology | 2007
Wayoon Poonperm; Goro Takata; Kenji Morimoto; Tom Birger Granström; Ken Izumori
Enzyme and Microbial Technology | 2005
Tom Birger Granström; Goro Takata; Kenji Morimoto; Matti Leisola; Ken Izumori